Pages that link to "Q48770145"

The following pages link to Use of melatonin to treat sleep disorders in tuberous sclerosis. (Q48770145):

Displaying 29 items.

• Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis (Q24537556) (← links)
• Medication for sleep-wake disorders (Q24675403) (← links)
• Melatonin Treatment in Children with Developmental Disabilities (Q27012836) (← links)
• Melatonin in Tuberous Sclerosis Complex Analysis Using Modern Mathematical Modeling Methods (Q33655732) (← links)
• Human aging and melatonin. Clinical relevance. (Q34280211) (← links)
• Pharmacological treatment of sleep disturbance in developmental disabilities: A review of the literature (Q34626830) (← links)
• Current management of tuberous sclerosis complex (Q34816124) (← links)
• Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary (Q35588990) (← links)
• Neuropsychiatric problems in tuberous sclerosis complex (Q35783807) (← links)
• Characterizing sleep disorders of adults with tuberous sclerosis complex: A questionnaire-based study and review (Q36226150) (← links)
• Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial (Q36372805) (← links)
• Melatonin and sleep disorders associated with intellectual disability: a clinical review (Q36689207) (← links)
• Role of the melatonin system in the control of sleep: therapeutic implications (Q37004418) (← links)
• Medical treatment in children with central nervous system malformations (Q37276249) (← links)
• Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment (Q37703975) (← links)
• What is the role of melatonin in the management of sleep disorders in children? (Q42426094) (← links)
• Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders (Q42633225) (← links)
• Melatonin for treatment of sleep disorders in children with developmental disabilities. (Q43711266) (← links)
• Melatonin in children and adolescents with insomnia: a retrospective study (Q44361110) (← links)
• The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders--a case series (Q46366317) (← links)
• Melatonin excretion in normal children and in tuberous sclerosis complex with sleep disorder responsive to melatonin. (Q46405309) (← links)
• Effect of melatonin dosage on sleep disorder in tuberous sclerosis complex. (Q46405312) (← links)
• A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities (Q46851680) (← links)
• Sleep disorders in Sanfilippo syndrome: a polygraphic study. (Q48640285) (← links)
• Melatonin for the treatment of handicapped children with severe sleep disorders (Q48711794) (← links)
• Melatonin improves sleep-wake patterns in psychomotor retarded children (Q48711809) (← links)
• Cognitive and behavioral correlates of tuberous sclerosis complex (Q50306912) (← links)
• Pediatric sleep disturbances and treatment with melatonin (Q64103912) (← links)
• Effects of neonatal melatonin administration on the extra-hypothalamic regions in rat brains: effects on the serotonergic system (Q74176254) (← links)